News

Gland Pharma Q4 Results 2025: Profit Dips 3% YoY to Rs 187 Crore, EBITDA Down 3%, 1800% Dividend Announced
FY25, Gland Pharma filed five Abbreviated New Drug Applications (ANDAs), with seven receiving approval. Over the course of ...
Belrise Industries IPO: Rs 2,150 Cr Fresh Issue Opens For Subscription Tomorrow; Is It Worth Subscribing?
The highly anticipated Belrise Industries IPO is set to open for subscription on Wednesday, May 21st, and has already created ...